<DOC>
	<DOCNO>NCT01069341</DOCNO>
	<brief_summary>The purpose study determine safety ranibizumab : ) surgical adjunct cataract surgery subject proliferative diabetic retinopathy ( PDR ) induce rubeosis , b ) treatment proliferative diabetic retinopathy ( PDR ) .</brief_summary>
	<brief_title>Use Ranibizumab Treat Rubeosis Diabetics Prior Cataract Surgery</brief_title>
	<detailed_description>This open-label , Phase I study intravitreally administer 0.5mg ranibizumab diabetic subject present initially dense cataract proliferative diabetic retinopathy induce rubeosis . Ten subject enrol single center 10 month period . Patients follow total 12 month treatment phase safety follow-ups Months 18 24 . Eligibility study entry determine principal investigator . Consented , enrol subject receive multiple open-label intravitreal injection 0.5 mg ranibizumab administer every month 3 dos ( load dose Day 0 Months 1 2 ) follow need re-treatment base specify criterion remainder study period . Subjects receive maximum eight injection ranibizumab study . All subject undergo cataract surgery first ranibizumab injection . Only one eye designate study eye duration study receive ranibizumab injection . All subject evaluate best correct Early Treatment Diabetic Retinopathy Study ( ETDRS ) visual acuity , intraocular pressure measurement , ophthalmological examination , slit lamp photography , gonioscopy , fundus photography , fundus fluorescein angiography Optical Coherence Tomography ( OCT ) . An ultrasound do need . Best correct ETDRS visual acuity intraocular pressure measurement perform eye .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Age 18 year Subjects diabetes mellitus Subjects proliferative diabetic retinopathy induce rubeosis Be willing undergo cataract surgery HgbA1c level &lt; 12 % History glaucoma surgery Active infectious conjunctivitis , keratitis , scleritis , endophthalmitis Intraocular surgery study eye within 60 day precede Day 0 History prior par plana vitrectomy study eye Positive pregnancy test HbA1c &gt; 12</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Rubeosis</keyword>
	<keyword>Neovascularization iris</keyword>
	<keyword>Proliferative diabetic retinopathy</keyword>
	<keyword>PDR</keyword>
	<keyword>Cataract</keyword>
</DOC>